Literature DB >> 8691072

Paradoxical effects of colchicine on the activation of human neutrophilis by chemotactic factors and inflammatory microcrystal.

C J Roberge1, M Gaudry, C Gilbert, S E Malawista, R de Médicis, A Lussier, P E Poubelle, P H Naccache.   

Abstract

Neutrophil activation by chemotactic factors and by inflammatory microcrystals is accompanied by increases in protein tyrosine phosphorylation and by the activation of the NADPH oxidase. The addition of colchicine inhibited both responses induced by triclinic monosodium urate or calcium pyrophosphate crystals. On the other hand, colchicine enhanced the tyrosine phosphorylation of specific protein in neutrophils stimulated by chemotactic factor and augmented the production of superoxide anions induced by these same agonists. The effects of colchicine were shared by other anti-microtubule agents (nocodazole and vinblastine) but not by its inactive analogue beta-lumicolchicine, trimethylcolchicinic acid, indomethacin, or phenylbutazone. Furthermore, the (enhancing as well as inhibitory) effects of colchicine on tyrosine phosphorylation and superoxide anion production were reversed by taxol. Finally, in human cytoplasts colchicine again inhibited microcrystal-stimulated tyrosine phosphorylation but did not change chemotactic factor-stimulated phosphorylation. These data strongly support the hypothesis that microtubule-related mechanisms are involved in the modulation of the tyrosine phosphorylation response in human neutrophils, and suggest that a relationship may exist between the augmentation of tyrosine phosphorylation and of the stimulation of the NADPH oxidase induced by chemotactic factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691072     DOI: 10.1002/jlb.59.6.864

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

Review 1.  Update on colchicine and its mechanism of action.

Authors:  Yair Molad
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

2.  Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine.

Authors:  E W Chia; R Grainger; J L Harper
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

3.  High-performance Thin-layer Chromatographic-densitometric Quantification and Recovery of Bioactive Compounds for Identification of Elite Chemotypes of Gloriosa superba L. Collected from Sikkim Himalayas (India).

Authors:  Ankita Misra; Pushpendra Kumar Shukla; Bhanu Kumar; Jai Chand; Poonam Kushwaha; Md Khalid; Ajay Kumar Singh Rawat; Sharad Srivastava
Journal:  Pharmacogn Mag       Date:  2017-10-11       Impact factor: 1.085

4.  Colchicine in COVID-19: an Old Drug, New Use.

Authors:  Naomi Schlesinger; Bonnie L Firestein; Luigi Brunetti
Journal:  Curr Pharmacol Rep       Date:  2020-07-18

Review 5.  Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.

Authors:  Fan-Shun Zhang; Qing-Ze He; Chengxue Helena Qin; Peter J Little; Jian-Ping Weng; Suo-Wen Xu
Journal:  Acta Pharmacol Sin       Date:  2022-01-19       Impact factor: 7.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.